Effective 1 de janeiro, 2024, the following updates will be made in MHK for the following InterQual subsets:
- CP Procedures: Decompression +/- Fusion Lumbar
- CP Procedures: Bariatric or Metabolic Surgery
- CP Molecular Diagnostics: BCR: ABL1 Testing in Acute Lymphoblastic Leukemia (ALL)
- CP Molecular Diagnostics: Cystic Fibrosis and Cystic Fibrosis Transmembrane Regulator (CFTR) Disorders
- CP Molecular Diagnostics: JAK2, CALR, or MPL related Myeloproliferative Neoplasms (MPN)
- CP Molecular Diagnostics: Pharmacogenomic Testing in NSCLC